cigna glp-1 coverage news today dropping obesity drug for employees (CI) Cigna dropping all GLP-1 coverage

The satiety effect is additive with GLP-1 agonism because the pathways don't overlap which is why CagriSema outperforms semaglutide monotherapy and tirzepatide on some endpoints

In addition, xCT expression can be regulated by the phosphoinositide 3-kinase/protein kinase B/mammalian target of rapamycin (PI3K/PKB/mTOR) 29,30,31 and mitogen-activated protein kinase (MAPK) pathways in synergy with activating transcription factor 4 (ATF4), which is activated by endoplasmic reticulum stress

therefore we must consume it through supplementation or diet

I wish even more, though, that my mother could have taken GLP-1s

The AI meal scanner is the other piece a spreadsheet genuinely can't replicate